Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
NEGG Newegg Commerce Inc
PHX PHX Minerals Inc
IRT Independence Realty Trust Inc
RLAY Relay Therapeutics Inc
CVU CPI Aerostructures Inc
MA Mastercard Inc
WDBG Neuro-Hitech Inc
GLRY Inspire Faithward Mid Cap Momentum ETF
WCC Wesco International Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$0.83
Day's Change
-0.0566 (-6.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.907
Day's Low
0.83
Volume
(Light)
Volume:
4,584,488

10-day average volume:
9,975,315
4,584,488

GRAINGER DECLARES QUARTERLY DIVIDEND

11:07 am ET January 25, 2023 (PR Newswire) Print

W.W. Grainger, Inc. (NYSE: GWW) announced today that its board of directors approved a quarterly cash dividend of $1.72 per share payable on March 1, 2023, to shareholders of record on February 13, 2023.

About GraingerW.W. Grainger, Inc., with 2021 sales of $13.0 billion, is a leading broad line distributor with operations primarily in North America, Japan and the United Kingdom. Grainger achieves its purpose, We Keep the World Working(R), by serving more than 4.5 million customers worldwide with a wide range of product categories that keep customer operations running and their people safe. The Company also delivers services and solutions, such as technical support and inventory management, to provide tangible value and save customers time and money. Grainger offers more than 2 million maintenance, repair and operating (MRO) products in its High-Touch Solutions assortment and more than 30 million products through its expanding Endless Assortment offering. For more information, visit invest.grainger.com.

https://c212.net/c/img/favicon.png?sn=CG95561&sd=2023-01-25

View original content:https://www.prnewswire.com/news-releases/grainger-declares-quarterly-dividend-301730592.html

SOURCE W.W. Grainger, Inc.

https://rt.newswire.ca/rt.gif?NewsItemId=CG95561&Transmission_Id=202301251107PR_NEWS_USPR_____CG95561&DateId=20230125

comtex tracking

COMTEX_423274555/1005/2023-01-25T11:07:55

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.